McKesson Corp

Incorporated in 1989, Otsuka America Pharmaceutical is a health care company that commercializes its products throughout North America. It offers products under the ABILIFY Tablets1 and PLETAL Tablets2 brands. The company works in collaboration with Bristol-Myers Squibb, which co-develops and co-promotes ABILIFY. Otsuka America Pharmaceutical has also merged with Meretek Diagnostics to form the Meretek Diagnostics Group under the Medical Device Division of OAPI. It focuses on neuroscience, cardiovascular, oncologic and gastrointestinal therapeutic treatments. The company operates Otsuka Maryland Research Institute, which was established as a wholly-owned subsidiary of OAPI to research and develop a variety of health care products. Otsuka America Pharmaceutical is a part of Otsuka Pharmaceutical Group.

Vanda Pharmaceuticals, headquartered in Rockville, Md., manufactures a range of prescription drugs. The company develops drugs for various diseases, such as insomnia and schizophrenia. It has expertise in the areas of pharmacogenetics and pharmacogenomics. The company has developed various biochemicals, such as Iloperidone, an antipsychotic and VEC-162, which is melatonin agonist under development for the treatment of sleep disorders. It conducts several clinical trials for development of medicines. The company has an on-site laboratory and a staff of trained professionals. The company s Web site provides information of its stock prices. It also provides analyst coverage for investors.

Takeda Pharmaceuticals in Washington, DC is a global pharmaceutical company dedicated to creating better health for people and a brighter future for the world. Through advancing science and technology, Takeda aims to transform lives and improve health outcomes. With a focus on research and development in areas such as gastrointestinal and inflammation, rare diseases, oncology, neuroscience, and vaccines, Takeda is committed to innovative solutions for complex medical challenges. The company's mission is to move science forward to deliver sustainable, patient-centered growth and make a positive impact on global health. Generated from the website